BSEOthers24 Aug 2026 · 24 Aug 2026, 06:15 pm

Submission of 38th Annual Report FY 2025-26

HandsOn Global Management (HGM)Ltd · 532761

✦ AI SummaryResults

HandsOn Global Management (HGM) Ltd has submitted its 38th Annual Report for FY 2025-26, which includes the notice of the 38th Annual General Meeting (AGM) scheduled for September 18, 2026, through video conferencing.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

HandsOn Global Management (HGM)Ltd - 532761 - Reg. 34 (1) Annual Report.

Attachments (1)

📄

a80140bf-f423-4e1d-9daa-59043838e925.pdf

pdf

Download →
View document text
August 24, 2026 To To National Stock Exchange of India Limited Bombay Stock Exchange Limited Exchange Plaza, Bandra Kurla Complex Floor 25, P. J. Tower, Dalal Street Bandra (East), Mumbai-400 051 Mumbai -400 001 NSE symbol: HGM BSE Scrip Code: 532761 Subject: Submission of 38th Annual Report for FY 2025-26 Reference: Regulation 30 & 34 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, This is to inform that the Company on August 24, 2026 had dispatched to the eligible shareholder/s, the Notice of 38th Annual General Meeting (“AGM”) along with the copy of Annual Report of FY 2025-26 in electronic mode and the same is available on the website www.hgmlimited.com of the Company. The 38th AGM is scheduled to be held on Friday, the September 18, 2026 at 10:30 AM (IST) through Video Conferencing (VC) or Other Audio Video Means (OAVM). The aforesaid 38th Annual Report for FY 2025-26 is enclosed herewith for submission to the Exchange. Kindly take the above on record. Thanking you, For HandsOn Global Management (HGM) Limited Bhuvanesh Sharma VP-Corporate Affairs, Company Secretary & Compliance Officer HandsOn Global Management (HGM) Limited (formerly known as HOV Services Limited) CIN: L72200PN1989PLC014448 Regd. Office: 4th Floor, Sharda Arcade, Pune Satara Road, Bibwewadi Pune - 411 037, Maharashtra, India Tel: +91-20 24221460 | Website: www.hgmlimited.com | Email: ir@hgmlimited.com Annual Report 2025-26 HOO SS Annual Report 2024-25 Table of Contents Parculars Page No. Corporate Informaon 2 Chairman Message to Shareholders' 4 Directors' Report 6 Management Discussion and Analysis Report 15 Corporate Governance Report 23 Consolidated Financial Statements: Auditors' Report 56-62 Financial Statement 63-112 Standalone Financial Statements: Auditors' Report 114-123 Financial Statement 124-169 Noce of 38th Annual General Meeng 170-184 HGM request the shareholders to aend its 38 Annual General Meeng to be held on September 18, 2026 through online mode. The 38 AGM will be held in video-conference mode in accordance with regulatory guidelines. Shareholders are requested to follow the instrucons in the Noce of 38 AGM to aend the meeng. Annual Report 2025-26 HOO SS Annual Report 2024-25 CORPORATE INFORMATION Registered Office & Head office HandsOn Global Management (HGM) Limited (Formerly known as HOV Services Limited) 4th Floor, Sharda Arcade, Pune Satara Road, Bibwewadi, Pune -411 037 Tel: (91 20) 24221460/ 67437415 Registrar & Share Transfer Agent KFin Technologies Ltd., Selenium Tower B, Plot No. 31 & 32, Financial District, Nanakramguda, Serilingampally Mandal, Hyderabad – 500032 Tel: (91 40)- 67161562 Statutory Auditors Lodha & Co LLP, Chartered Accountants, 6, Karim Chambers, 40, A, Doshi Marg, (Hamam Street), Mumbai-400 001 Tel: (91 22)- 2269 1414 Secretarial Auditor Ruchi Bhave, Praccing Company Secretary Flat No. 7, Karan Aniket, Level 4, Plot No. 37, Shri Varanasi Co-op Soc. Ltd, Off Banglore Mumbai Bangalore Bypass, Behind Atul Nagar, Warje, Pune- 411058 Tel: (91 20)- 61097702 Internal Auditors Arth & Associates, Chartered Accountants Flat No. 102/103, Beena Apartments, Behind Chrysallis Instute, Opp. SBI Bank, S. B. Road, Pune- 411016 Tel: +91 75584 93309 VP- Corporate Affairs & Company Mr. Bhuvanesh Sharma Secretary & Compliance Officer investor.relaons@hgmlimited.com Chief Financial Officer Mr. Nilesh Bafna investor.relaons@hgmlimited.com Website www.hgmlimited.com THE BOARD OF DIRECTORS Mr. Parvinder S Chadha Chairman & Execuve Director & Promoter Mr. Sunil Vasant Rajyadhyaksha Execuve Director & Promoter Mr. Vikram Negi¹ Execuve Director Mr. Harjit Singh Anand Independent Director Mr. Ajay Puri Independent Director Mrs. Lakshmi Kumar² Independent Director Mrs. Bhavana Sharma³ Independent Director Mr. Kesavan Nair Padmanabhan ⁴ Independent Director 1-Office vacated effecve December 10, 2025 2-Office vacated effecve July 12, 2025 3-Appointed effecve October 15, 2025 4-Appointed effecve March 7, 2026 Annual Report 2025-26 HOO SS Annual Report 2024-25 THE EXECUTIVE MANAGEMENT Mr. Parvinder S Chadha Execuve Chairman & Promoter Mr. Sunil Vasant Rajyadhyaksha Execuve Director & Promoter Dr. Bhargav Thakkar Execuve VP-Healthcare Services Mr. Bhuvanesh Sharma VP-Corporate Affairs & Company Secretary & Compliance Officer Mr. Nilesh Bafna Chief Financial Officer COMMITTEES OF THE BOARD OF DIRECTORS AUDIT COMMITTEE Name Designaon/Category Mr. Harjit Singh Anand Chairman (Independent Director) Mrs. Bhavana Sharma Member (Independent Director) Mr. Ajay Puri Member (Independent Director) Mr. Parvinder S Chadha Member (Execuve Director) NOMINATION & REMUNERATION COMMITTEE Name Designaon/Category Mrs. Bhavana Sharma Chairman (Independent Director) Mr. Harjit Singh Anand Member (Independent Director) Mr. Ajay Puri Member (Independent Director) Mr. Parvinder S Chadha Member (Chairman & Execuve Director) STAKEHOLDERS RELATIONSHIP COMMITTEE Name Designaon/Category Mr. Ajay Puri Chairman (Independent Director) Mr. Harjit Singh Anand Member (Independent Director) Mr. Sunil Vasant Rajyadhyaksha Member (Execuve Director) AAnnnnuuaall RReeppoorrtt 22002255--2266 HOO SS Annual Report 2024-25 Dear Shareholders, It is my privilege to welcome you to the 38 Annual General Meeng of your Company and to present the Annual Report for the financial year 2025–26. This year's Annual General Meeng is being conducted through video conferencing, enabling broader parcipaon by our shareholders across geographies and reflecng our connued commitment to transparency, accessibility, and good corporate governance. Financial year 2025–26 marks a defining chapter in the evoluon of our Company. During the year, we embarked on a strategic transformaon with the adopon of a new corporate identy that reflects our renewed vision, evolving business strategy, and long- term commitment to creang sustainable value for all stakeholders. This transformaon represents far more than a change in branding—it signifies our transion into a technology-led enterprise focused on arficial intelligence, intelligent automaon, and digital innovaon. A significant milestone during the year was the acquision of Aidéo Technologies LLC, an AI-powered autonomous medical coding plaorm. This strategic acquision strengthens our posion in one of the fastest-growing segments of healthcare technology and aligns with our vision of applying advanced arficial intelligence to improve the efficiency, quality, and economics of healthcare delivery. As healthcare systems worldwide connue their digital transformaon, AI-enabled soluons are becoming indispensable in improving operaonal performance, clinical documentaon, coding accuracy, compliance, and paent outcomes. The acquision substanally expands our capabilies across healthcare revenue cycle management, autonomous medical coding, ambient clinical documentaon, care management, healthcare analycs, and intelligent enterprise workflows. By integrang advanced AI technologies with our deep healthcare experse, we are building a differenated plaorm capable of delivering measurable value to healthcare providers, payers, employers, and healthcare technology partners. Looking ahead, our strategic focus extends well beyond tradional healthcare services. We believe the next decade will be defined by the emergence of Agenc Arficial Intelligence—intelligent autonomous systems capable of reasoning, planning, collaborang, and execung complex business processes with minimal human intervenon. Accordingly, the Company connues to explore strategic opportunity in technology, talent and AI-enabled plaorms to strengthen its posion in healthcare administraon services, with a strategic focus on Revenue Cycle Management (RCM) and related healthcare soluons. Our objecve is to build intelligent plaorms that automate complex healthcare workflows spanning paent access, clinical documentaon [Showing first 8,000 characters — download PDF for full document]